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Nef and PAK: virulence factor and cellular accomplice 
Didier Trono and JewKuei Wang 
The Nef protein is important in HIV replication and in AIDS 
pathogenesis. The finding that Nef activates a member of 
the PAK family of protein kinases provides new insights into 
the mechanisms of action of this critical virulence factor. 
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The genomic complexity of lentiviruses sets them apart 
from other retroviruses. Oncoretroviruses contain only the 
prototypic gag, pal and erzv genes, but the human and simian 
immunodeficiency viruses (HIV and SIV, respectively) 
have six to seven additional reading frames. Some of these 
encode proteins that are not essential for viral replication in 
vitro, and are therefore called accessory proteins. This 
appellation is misleading, because the accessory proteins of 
primate lentiviruses are essential virulence factors in viva, 
and are therefore valuable targets for the development of 
antiviral therapies. One of these proteins, Nef, was revealed 
to be essential for high levels of viral replication and for 
disease progression, at least in adult animals, in studies 
using the SW/rhesus macaque model of AIDS pathogenesis 
[l]. More recently, strains of HIV-l that are defective in 
Nef function have been suggested to be important in some 
cases of patients who have been infected with HIV-l for 
long periods but have not progressed to disease [2,3]. Thus, 
drugs that block the activity of Nef might well be useful in 
the treatment of HIV-l infection. 
Effects of Nef on the virus and its host cell 
Nef is a small cytoplasmic protein that associates with the 
plasma membrane and the cytoskeleton through its myris- 
toylated amino terminus. It is produced from the earliest 
stage of viral gene expression, affecting both the kinetics 
of virus replication and the biology of the host cell. First, 
Nef stimulates the infectivity of HIV particles, apparently 
by increasing the efficiency of reverse transcription. 
Although it is possible that this might be a direct effect, 
because some Nef is found in viral particles, recent data 
suggest that Nef enhances the serine phosphorylation of the 
matrix protein, which is a component of the reverse tran- 
scription complex, and its effects might thus be indirect (S. 
Swingler, P. Gallay, J. Song and D.T., unpublished observa- 
tions). Nef also induces the down-regulation of CD4, one of 
the cellular receptors for HIV-l, and of major histocompati- 
bility complex (MHC) class I molecules, although this 
down-regulation is less profound. Nef causes accelerated 
internalization of these cell-surface molecules by acting as a 
physical connector to the endocytic apparatus [4]. Finally, 
Nef alters cellular activation pathways, although there is 
controversy about how it does so. Defective activation pat- 
terns have been reported in human T lymphoid cell lines, or 
in murine fibroblastic cell lines that stably express Nef 
[S-7], but elevated signaling has been observed in other 
systems, including thymocytes from neftransgenic mice [S]. 
In one study, Nef activated T-cell signaling when bound to 
the plasma membrane, but inhibited it when retained in the 
cytosol [9]. To explain this paradox it was proposed that Nef 
sequesters a putative signaling molecule that is active only 
when localized at the plasma membrane. 
Nef and protein kinases 
Nef has no known catalytic activity, so it is likely to exert 
its effects via cellular proteins, particularly those involved 
in signal transduction. Nef has so far been shown to associ- 
ate with two kinds of protein kinases. First, it binds to 
some members of the Src family of tyrosine kinases. This 
interaction is mediated through the recognition of a con- 
served (PxxP) repeat in Nef by the SH3 domain of these 
enzymes [l&11]. Although the exact nature of the Src- 
related kinase that binds to Nef within the context of 
infected cells is as yet unknown, functional evidence sug- 
gests that it participates in stimulating viral replication 
[lo]. Second, a cellular serine/threonine kinase activity 
can be immunoprecipitated with Nef proteins from HIV 
and SIV [12]. in ah-o, this activity phosphorylates sub- 
strates of 62 kDa and 72 kDa that are also bound to Nef. 
The larger protein, ~72, is detected in T lymphoid cells 
but not in COS cells, suggesting that it might be a lym- 
phocyte-specific substrate for the Nef-associated kinase. 
Nef only binds to the protein serine kinase activity when 
it is associated with the plasma membrane, and binding 
requires the presence of two arginine residues within the 
central region of the viral protein [ 131. 
IJntil recently, the identity and functional importance of 
the Nef-associated serine kinase were unknown. Three 
recent papers have shed some light on this question 
[14-lo]. Nunn and Marsh [14] first showed that the Nef- 
associated kinase can be immunoprecipitated using anti- 
bodies to a member of the family of p21-activated kinases 
(PAKs). PAKs are highly conserved, ubiquitous protein 
serine kinases that are activated after associating with the 
~21 Rho-like GTP-binding proteins Racl and Cdc42Hs, 
which themselves are functionally linked to various 
growth factor and mitogen receptors. PAKs are the most 
upstream enzymes of a cascade that leads to the activation 
of mitogen-activated protein kinases (MAPK) such as the 
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c-jun amino-terminal kinase (JNK), and have been impli- 
cated in a variety of processes including cellular activation 
and actin polymerization [17-201. In T lymphocytes, one 
member of the PAK family could participate in stimulat- 
ing the activity of inducible Jun-containing transcription 
factors such as NF-AT and NF-IL& and thus in the 
response to CD3-CD28 costimulation, via a pathway 
involving the activation of JNK [Zl]. 
Nunn and Marsh [14] also found that the Nef-associated 
serine kinase, like members of the PAK family, could 
readily use histone H4 as a substrate and was stimulated 
by overexpression of constitutively activated (i.e. GTP- 
bound) forms of Racl and Cdc42. Taken together with 
the serological evidence, these data suggest that the Nef- 
associated kinase may also be part of the PAK family. 
Two further publications [15,16] confirm and extend 
these data. Sawai et al. [15] and Lu et al. [16] also showed 
that antibodies against PAKs could recognize the protein 
serine kinase activity associated with HIV-l or SIV Nef in 
either Nef-expressing or virus-infected cells, and detected 
62 kDa and 7’2 kDa phosphoproteins after performing in 
vitro kinase assays on PAK immunoprecipitates obtained 
from these cells. Sawai et al. [15] further showed, using 
partial chymotryptic digestion, that the p62 and ~72 
proteins had different patterns, but that the pattern for 
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each protein was identical whether the material was recov- 
ered from SIV Nef immunoprecipitates or from anti-PAK 
antibody immunoprecipitates [15]. 
Transient expression assays, in vitro transcription and 
translation experiments and partial proteolytic digests indi- 
cate that the Nef-associated kinase is distinct from all 
known PAKs [14,16]. Expression of a dominant negative 
form of human PAK65 (hPAK65), containing the GTPase- 
binding region but lacking the kinase domain of this 
protein, blocked the activity of the Nef-associated kinase, 
however. Thus the Nef-associated kinase, like other PAKs, 
appears to bind to the GTPases Cdc42 and Racl [16]. 
Similarly, dominant-negative forms of Cdc42 and Racl 
inhibit the Nef-associated kinase [ 161. 
Importance of the Nef-PAK association 
The functional significance of the association between 
Nef and members of the PAK family of kinases is not yet 
clearly established, but both tissue culture experiments 
and studies performed in the SIV/rhesus macaque model 
provide evidence for its physiological relevance (Fig. 1). 
We recently found that an HIV-l variant expressing a Nef 
mutant protein that was unable to recruit the protein 
serine kinase activity had lower levels of matrix serine 
phosphorylation than wild-type HIV-l. These results may 
provide the link between Nef, its associated kinase, and 
CD4 (or MHC class I) 
Proposed model for the Nef-PAK connection. 
The three known phenotypic effects of Nef are 
indicated in red. Nef-induced activation of a 
PAK-related protein serine kinase (PAK-X) 
could result in activating a number of 
transcription factors associated with T-cell 
activation. In parallel, PAK could promote the 
infectivity of virions by stimulating the 
phosphorylation of the matrix protein, one of 
the virus major structural components. Finally, 
the GTPases Rho and Rat have been shown 
to regulate receptor-mediated endocytosis 
1231. It is unclear whether Nef affects this 
pathway, however, as the only molecules 
found to be down-regulated by Nef are CD4 
and, to a lesser extent, MHC class I, 
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the stimulation of HIV-l proviral DNA synthesis (S. 
Swingler, P. Gallay, J. Song and D.T., unpublished obser- 
vations). The same mutant Nef allele could still down- 
regulate CD4, albeit less efficiently than wild-type [ZZ]. 
Lu et al. [16] observed that expressing dominant negative 
forms of hPAK65, or of Racl and Cdc42, decreased the 
efficiency of viral particle production from COS cells that 
had been transiently transfected with a wild-type, but not a 
n&deleted, HIV-l proviral DNA construct. They also 
noted that the levels of virion release were significantly 
lower with n&deleted virus than with wild-type virus. This 
result is quite puzzling, since no other group has previously 
reported a positive effect of Nef on the efficacy of viral par- 
ticle production. Finally, they found that Nef activates the 
serum-response pathway, a known target of small GTPases 
[19], via the Nef-associated kinase, Cdc42 and Racl [16]. 
The implications of this result, obtained in transiently 
transfected murine fibroblasts, are not obvious. It is possi- 
ble that this phenomenon relates to the ability of Nef to 
alter T-cell activation pathways; perhaps Nef modifies 
infected cells to the benefit of viral production. 
To determine the importance of the Nef-associated serine 
kinase in viva, Sawai et a/. [ 151 used an SIV variant contain- 
ing a mutation in Nef that abrogates binding to and activa- 
tion of the Nef-associated protein serine kinase. Rhesus 
macaques infected with this virus at first had lower viral 
loads than those infected with wild-type virus, but then 
rapidly reverted to the normal course of infection, while at 
the same time the virus reverted to a wild-type Nef geno- 
type. This result shows that the mutated residues, two 
arginines in the core domain of Nef are crucial for the life 
cycle of the virus, implying that the Nef-associated kinase 
is itself essential for viral replication and in AIDS patho- 
genesis,. One cannot, however, formally exclude the possi- 
bility that the mutation might have affected other aspects 
of Nef function, especially since the two arginines are 
located within the conserved central region of the protein, 
and one of them at least may be structurally important [ll]. 
Future directions 
Future experiments should further explore the influence of 
the Nef-associated kinase on the replication of the primate 
lentiviruses and on AIDS pathogenesis. One important task 
will be to formally identify which member of the PAK 
family associates with Nef. The eventual determination of 
the three-dimensional structure of the complex formed by 
the viral protein and its cellular accomplice should be an 
important step towards the discovery of inhibitors, and will 
considerably assist in the dissection of the pathways 
affected by this kinase. These studies will not only provide 
insight into the effects of this enzyme on the viral life-cycle, 
but will also help us to determine what it normally does in 
the cell. In this case, as frequently happens, the study of a 
virus may lead to breakthroughs in the understanding of 
basic cellular phenomena. 
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